Skip to content

Stepan

US · SCL #3013 by market cap Listed 1970
63.48 -1.52 -2.34%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Valuation each multiple against its own 5-year range

P/B ratio 1.24 In line with history 37th percentile
5-year average 1.52 · #18 of 59 in Specialty Chemicals
P/E ratio 349.37 Expensive vs history 99th percentile
5-year average -3.53 · forward 23.25 · #35 of 36 in Specialty Chemicals
P/S ratio 0.60 Cheap vs history 30th percentile
5-year average 0.74 · forward 0.55 · #13 of 61 in Specialty Chemicals

Vs. peers Specialty Chemicals

Company Market cap P/E (TTM) P/B Div yield
Stepan (SCL) 1.44B 334.11 1.18 2.49%
Linde (LIN) 230.84B 33.39 5.86 1.25%
Ecolab (ECL) 82.65B 40.10 7.93 0.99%
Sherwin-Williams (SHW) 82.08B 31.25 20.64 0.94%
Air Products & Chemicals (APD) 66.16B 124.31 4.63 2.43%
PPG Industries (PPG) 25.87B 16.71 3.05 2.45%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value73.65 Economic moatNone UncertaintyLow

Trading 16.0% below Morningstar's fair value estimate.

Fair value

Stepan Co receives a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 10% discount to our quantitative fair value estimate of $73.65 per share, which is reinforced by this estimate's low uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The company's valuation metrics bolster our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 80.1%, which ranks in the top 40% compared with global peers. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.

The firm's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's sales yield of 165.4%, for example, sits in the top 30% compared with global peers. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. This characteristic further promotes our favorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-11-20 20:01:34 · For reference only, not investment advice and not tailored to your situation.

Stepan discussion 0 comments

Add a comment